Sigma Healthcare Ltd · ASX:SIG
Sigma Healthcare — Shareholder Meeting (May 2024)
18 slides from Sigma Healthcare's shareholder meeting presentation, May 30, 2024
Slide 1: Annual General Meeting 2024
Annual General For personal use only Meeting 2024 30 May 2024
Slide 2: Chairman address
For personal use only Michael Sammells Chairman We acknowledge the Wurundjeri people of the Kulin Nation and acknowledge them as the Traditional Custodians of the land on which we meet today. We pay our respects to their Elders past, present and emerging. Sigma Healthcare Limited - Annual General Me
Slide 3: Board of Directors
Board of Directors For personal use only Michael Sammells Vikesh Ramsunder Annette Carey Neville Mitchell Kathryn Spargo Dr Chris Roberts Sigma Healthcare Limited - Annual General Meeting 2024
Slide 4: Order of Business
Order of Business 1. Chairman and CEO addresses For personal use only 2. Formal items of business • Financial Statements and Reports • Remuneration Report • Re-election of Directors • Remuneration arrangements for the MD and CEO. Sigma Healthcare Limited - Annual General Meeting 2024
Slide 5: FY2024 At A Glance
FY2024 At A Glance FY24 has delivered sustained improvements and For personal use only significant strategic achievements that can fundamentally transform Sigma for the long term ▪ Strengthened our core operating business, improved efficiencies and expanded our growth opportunities ▪ Renewed our Boa
Slide 6: Transformational proposed merger
Transformational proposed merger ▪ The biggest transformational opportunity in the long and proud For personal use only history of Sigma ▪ Will create a full-service wholesaler, distributor and retail pharmacy franchisor ▪ Accelerates our strategic direction by bringing together two complementary bu
Slide 7: A stronger Sigma standalone
A stronger Sigma standalone Share Price up 100% in 12-months 1.4 1.3 1.2 For personal use only 1.1 1 ▪ Completed our two-year turnaround 0.9 0.8 ▪ State-of-the-art distribution centre network with 0.7 0.6 capacity for growth 0.5 ▪ Strong heritage brands ▪ Pipeline of private and exclusive label prod
Slide 8: ESG update
ESG update For personal use only ▪ Released our fourth Sustainability Report ▪ Facilitated the donation of $2.2 million of health products to Food Bank ▪ Reached over 23% consumption of solar electricity as a proportion of total energy consumed ▪ Diverted over 71% of our waste away from landfill acr
Slide 9: Thank you
For personal use only Thank you Sigma Healthcare Limited - Annual General Meeting 2024
Slide 10: Vikesh Ramsunder, CEO and Managing Director
For personal use only Vikesh Ramsunder CEO and Managing Director Sigma Healthcare Limited - Annual General Meeting 2024
Slide 11: Agenda
Agenda For personal use only 1. Overview of financial performance 2. Update on operational performance 3. Outline retail brand strategy progress 4. Discuss the Regulatory environment 5. Current year update Sigma Healthcare Limited - Annual General Meeting 2024
Slide 12: Financial Performance for FY24
Financial Performance for FY24 Net Sales of $3.3 billion For personal use only Excluding merger proposal costs* • Earnings Before Interest and Tax (EBIT) of $31.4 million • Net Profit After Tax (NPAT) of $12.7 million Including merger proposal costs • EBIT was $23.2 million • NPAT was $4.5 million,
Slide 13: Operational Performance
Operational Performance Reliability of our operational performance For personal use only continues to be a highlight We have delivered over 230 million units during the year Delivery in Full sustained above 99% - world class levels Stock availability improved to 93%, and stock on hand reduced by $10
Slide 14: Brand strategy
Brand strategy After announcing our plans to consolidate our brands, this process is now well For personal use only advanced, allowing us to: • Provide more support to the Amcal and Discount Drug Store brands • Focus on brand positioning and consumer messaging Further, we have: • Planned the launch
Slide 15: Regulatory update
Regulatory update For personal use only • Sigma operates in a highly regulated industry with agreements in place that regulate our wholesale distribution margin for PBS medicines • CSO Deeds and its related funding is critical in ensuring the sustainability of an essential service that delivers a ke
Slide 16: Current year update
Current year update • The macro-economic environment remains challenging For personal use only and intensely competitive • Sigma operates in a more defensive market segment, with sales for first quarter of this financial year up 4.9% • Our pursuit of a medium-term EBIT margin of 1.5% to 2.5% remains
Slide 17: Thank you
For personal use only Thank you
Slide 18: Important Notice
Important Notice The information contained in this presentation about Sigma Healthcare Limited and its subsidiaries (Sigma) is designed to provide: • an overview of the financial and operational highlights for Sigma for the full year period ending 31 January 2024; and For personal use only • a high